Patzer Eric's Form 4 filing
Aridis Pharmaceuticals, Inc. (ARDS) · filed Jun 28, 2024
- Accession no.
- 0001493152-24-025672
- Filed
- Jun 28, 2024, 7:32 PM ET
- Trade date
- Jun 24, 2024
- Filing delay
- 4 daysLate
- Rule 10b5-1 plan
- Not checked
This filing lists 1 non-derivative transaction and 0 derivative transactions. Open-market purchases total $50.0K. It was filed 4 days after the trade, past the 2-business-day deadline.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Patzer EricCIK 0001749992 | Director |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Jun 24, 2024 | Common stock purchase | PPurchaseAcquired | +714,286 | $0.07 | +$50,000.02 | 884,600 | Direct |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.